 |
golimumab |
|---|---|
| Trade Name | Simponi Aria |
| Orphan Indication | Polyarticular juvenile idiopathic arthritis in patients 0 through 18 years of age |
| USA Market Approval | USA |
| USA Designation Date | 2015-04-02 00:00:00 |
| Sponsor | Janssen Research & Development, LLC;1400 McKean Road;Spring House, Pennsylvania, 19477 |
